Accent Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.6K Hold
50
– – 0.01% 171
2026
Q2
$16.7K Hold
50
– – 0.01% 168
2026
Q1
$16.1K Hold
50
– – 0.01% 163
2025
Q4
$14.7K Buy
+50
New +$9.31K 0.01% 161

Other funds holding PRAX

Accent Capital Management's PRAX Position: Q3 2026 in Review

Accent Capital Management held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 50 shares worth $14.6K. The position accounts for 0.01% of the portfolio, ranked #171.

Accent Capital Management first reported a position in PRAX in Q4 2025 and has held it in 4 quarters since. The position peaked at $16.7K in Q2 2026. 278 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Accent Capital Management held 50 shares of Praxis Precision Medicines worth $14.6K as of Q3 2026.
  • Accent Capital Management left its Praxis Precision Medicines share count unchanged in Q3 2026.
  • Praxis Precision Medicines made up 0.01% of Accent Capital Management's portfolio in Q3 2026, its #171 holding.
  • Accent Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 4 quarters since.
  • Accent Capital Management's Praxis Precision Medicines position peaked at $16.7K in Q2 2026.
  • 278 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Accent Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.